Document is current
Any future updates will be listed below
-
Authors
Rohde, David https://orcid.org/0000-0002-3785-9375
Vandoorne, Katrien
Lee, I-Hsiu https://orcid.org/0000-0001-7200-7867
Grune, Jana
Zhang, Shuang https://orcid.org/0000-0001-5570-5954
McAlpine, Cameron S.
Schloss, Maximilian J.
Nayar, Ribhu
Courties, Gabriel
Frodermann, Vanessa https://orcid.org/0000-0001-5566-6692
Wojtkiewicz, Gregory https://orcid.org/0000-0002-3148-8411
Honold, Lisa
Chen, Qi https://orcid.org/0000-0001-8485-6540
Schmidt, Stephen
Iwamoto, Yoshiko
Sun, Yuan
Cremer, Sebastian
Hoyer, Friedrich F.
Iborra-Egea, Oriol https://orcid.org/0000-0002-7280-859X
Muñoz-Guijosa, Christian
Ji, Fei
Zhou, Bin https://orcid.org/0000-0001-5278-5522
Adams, Ralf H. https://orcid.org/0000-0003-3031-7677
Wythe, Joshua D.
Hidalgo, Juan https://orcid.org/0000-0003-0921-1122
Watanabe, Hideto
Jung, Yookyung
van der Laan, Anja M.
Piek, Jan J.
Kfoury, Youmna
Désogère, Pauline A.
Vinegoni, Claudio https://orcid.org/0000-0002-9818-3639
Dutta, Partha
Sadreyev, Ruslan I.
Caravan, Peter https://orcid.org/0000-0002-3179-6537
Bayes-Genis, Antoni
Libby, Peter https://orcid.org/0000-0002-1502-502X
Scadden, David T.
Lin, Charles P.
Naxerova, Kamila
Swirski, Filip K. https://orcid.org/0000-0002-3163-9152
Nahrendorf, Matthias https://orcid.org/0000-0002-4021-1887
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (HL142494)
- License Information
-
More Information
Article History
Received: 9 June 2021
Accepted: 27 October 2021
First Online: 23 December 2021
Competing interests
: M.N. has received funds or material research support from Alnylam, Biotronik, CSL Behring, GlycoMimetics, GSK, Medtronic, Novartis and Pfizer, as well as consulting fees from Biogen, Gimv, IFM Therapeutics, Molecular Imaging, Sigilon, Lilly and Verseau Therapeutics. The authors declare no competing interests.
